Yanagi Hidetoshi, Nakanishi Michio, Konishi Harumi, Yamada Saori, Fukui Noriyuki, Kitagaki Kazufumi, Fujii Sayako, Kohzuki Masahiro
Department of Cardiovascular Rehabilitation, National Cerebral and Cardiovascular Center Suita Japan.
Department of Internal Medicine and Rehabilitation Science, Disability Science, Tohoku University Graduate School of Medicine Sendai Japan.
Circ Rep. 2019 Jan 18;1(2):55-60. doi: 10.1253/circrep.CR-18-0015.
Cardiac resynchronization therapy (CRT) is an effective treatment of heart failure (HF) with ventricular dyssynchrony, but not all patients respond to a similar extent. We investigated the efficacy and safety of exercise training (ET) in patients without response to CRT. Thirty-four patients who participated in a 3-month ET program and underwent cardiopulmonary exercise testing at baseline and after the program were divided into 17 responders and 17 non-responders based on echocardiographic response criteria: either an increase in ejection fraction (EF) ≥10% or a reduction in left ventricular (LV) end-systolic volume ≥10%. Baseline characteristics including peak oxygen uptake (V̇O) and isometric knee extensor muscle strength (IKEMS) were similar in both groups, but non-responders had lower EF and larger LV. During the ET program, neither group had exercise-related adverse event including life-threatening ventricular arrhythmia. Peak V̇O and IKEMS were significantly improved in both groups and there was no significant difference in change in peak V̇O or IKEMS between responders and non-responders. On multiple regression analysis, change in IKEMS was an independent predictor of change in peak V̇O, whereas the response to CRT was not. In HF patients undergoing CRT implantation, ET safely improved exercise capacity regardless of response to CRT, suggesting that even advanced HF patients without response to CRT can possibly benefit from ET.
心脏再同步治疗(CRT)是治疗伴有心室不同步的心力衰竭(HF)的有效方法,但并非所有患者的反应程度都相似。我们研究了运动训练(ET)对CRT无反应患者的疗效和安全性。34名参加为期3个月ET计划并在基线和计划结束后接受心肺运动测试的患者,根据超声心动图反应标准分为17名反应者和17名无反应者:射血分数(EF)增加≥10%或左心室(LV)收缩末期容积减少≥10%。两组的基线特征包括峰值摄氧量(V̇O)和等长伸膝肌力量(IKEMS)相似,但无反应者的EF较低,LV较大。在ET计划期间,两组均未发生包括危及生命的室性心律失常在内的与运动相关的不良事件。两组的峰值V̇O和IKEMS均显著改善,反应者和无反应者之间的峰值V̇O或IKEMS变化无显著差异。多元回归分析显示,IKEMS的变化是峰值V̇O变化的独立预测因素,而对CRT的反应则不是。在接受CRT植入的HF患者中,ET安全地提高了运动能力,无论对CRT的反应如何,这表明即使是对CRT无反应的晚期HF患者也可能从ET中获益。